Skip Navigation

European Journal of Heart Failure 2002 4(1):117-118; doi:10.1016/S1388-9842(01)00228-8
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Metcalfe, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Metcalfe, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2002 European Society of Cardiology

Comment on "Hospital admission following a diagnosis of heart failure: is time to first admission telling us what we want to know?"

Chris Metcalfe

Joint MRC/NHS Eastern Region Training Fellow MRC Biostatistics Unit Institute of Public Health University Forvie Site Robinson Way Cambridge CB2 2SR, UK

The first 10% of the full text of this article appears below.

Having, in the past, enjoyed working with Marcelo Shibata and Marcus Flather, I read with interest their recent contribution to the European Journal of Heart Failure [1]. Their systematic review elucidates the accumulating evidence of the effectiveness of beta-blocker treatment in heart failure. The near equal effect of beta-blockers on both mortality and hospitalisation for heart failure indicates the efficacy of this treatment both in prolonging life and in improving the quality of life through the avoidance of unplanned hospital stays.

However, it is not true to say that the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?